IPLTF (Implantica AG) Debt-to-Asset : 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Implantica AG Debt-to-Asset?

Implantica AG IPLTF Debt-to-Asset is 0.00 as of . 20.

Implantica AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Implantica AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Implantica AG's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was $0.00 Mil.

Implantica AG  (OTCPK:IPLTF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Implantica AG Debt-to-Asset Related Terms

Implantica AG Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Implantica AG's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implantica AG Debt-to-Asset Chart

Implantica AG Annual Data
Trend
Debt-to-Asset

Implantica AG Semi-Annual Data
Debt-to-Asset

IPLTF vs : Debt-to-Asset Comparison

For the Medical Devices subindustry, Implantica AG's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Implantica AG Debt-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Implantica AG's Debt-to-Asset falls into.


Implantica AG Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Implantica AG's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

Implantica AG's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.00 mean?
Implantica AG (IPLTF) has a Debt-to-Asset of 0.00 as of . 20. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Implantica AG and its competitors.
Is Implantica AG's Debt-to-Asset too high?
Implantica AG's current Debt-to-Asset is 0.00.
How does Implantica AG's Debt-to-Asset compare to ?
Implantica AG's Debt-to-Asset of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Devices & Instruments company?
A good Debt-to-Asset depends on the Medical Devices & Instruments industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Implantica AG and its competitors. Implantica AG's current Debt-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (IPLTF) has a current Debt-to-Asset of 0.00. The current Debt-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Implantica AG (IPLTF), the current Debt-to-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Implantica AG Business Description

Comparable Companies
Other Exchanges IMP A SDB:Sweden
Address Aeulestrasse 15, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.